Maternal variable | Newborn and children HPV-DNA | |||
---|---|---|---|---|
 | Positive (n = 12) | Negative (n = 37) | ||
Type of HPV lesion | Â | Â | Â | Â |
Genital warts | 7 | (58.3%) | 21 | (56.8%) |
LGSIL1 | 2 | (16.7%) | 10 | (27%) |
HGSIL2 | 3 | (25%) | 6 | (16.2%) |
Site of HPV lesion | Â | Â | Â | Â |
Uterine cervix | 5 | (41.7%) | 16 | (43.2%) |
Vulva | 4 | (33.3%) | 12 | (32.4%) |
Vulva + vagina | 2 | (16.7%) | 5 | (13.5%) |
Vulva + perineal region | - | - | 1 | (2.7%) |
Uterine cervix + vulva + vagina | 1 | (8.3%) | 3 | (8.2%) |
Type of HPV Infection | Â | Â | Â | Â |
Single | 6 | (50%) | 13 | (35.2%) |
Double | 1 | (8.3%) | 14 | (37.8%) |
Multiple | 5 | (41.7%) | 10 | (27%) |
Type of delivery | Â | Â | Â | Â |
Vaginal | 5 | (41.7%) | 18 | (48.6%) |
Vaginal + forceps | - | - | 1 | (2.7%) |
Cesarean section | 7 | (58.3%) | 18 | (48.6%) |
Mean of the gestational age at delivery in the newborn HPV-DNA positive group (39.3 ± 0.9 weeks) |  |  |  |  |
Mean of the gestational age at delivery in the newborn HPV-DNA negative group (39.3 ± 2.4 weeks) |  |  |  |  |
Gestational age at the time HPV infection was diagnosed (weeks) | Â | Â | Â | Â |
≥ 4 to ≤ 12 | 4 | (33.3%) | 15 | (40.5%) |
≥ 13 to ≤ 28 | 4 | (33.3%) | 8 | (21.6%) |
≥ 29 to ≤ 42 | 2 | (16.7%) | 6 | (16.3%) |
Prior to pregnancy | 2 | (16.7%) | 8 | (21.6%) |
Mean in the newborn HPV-DNA positive group (14.6 ± 13.6 weeks) |  |  |  |  |
Mean in the newborn HPV-DNA negative group (13.3 ± 12 weeks) |  |  |  |  |
Time of RUPREME 3 (min) | Â | Â | Â | Â |
≤ 360 | 12 | (100%) | 34 | (91.9%) |
≥ 361 to ≤ 720 | - | - | 1 | (2.7%) |
≥ 721 | - | - | 2 | (5.4%) |
Mean of newborn HPV-DNA positive group (39 ± 56 minutes) | - | - | - | - |
Mean of newborn HPV-DNA negative group (103 ± 240 minutes) | - | - | - | - |
Time of labor (min) | Â | Â | Â | Â |
≤ 240 | 6 | (50%) | 22 | (61.1%) |
≥ 241 to ≤ 360 | 3 | (25%) | 9 | (25%) |
≥ 361 | 3 | (25%) | 6 | (13.9%) |
Mean of newborn HPV-DNA positive group (213 ± 225 minutes) | - | - | - | - |
Mean of newborn HPV-DNA negative group (194 ± 196 minutes) | - | - | - | - |
HPV lesion at delivery | Â | Â | Â | Â |
Yes | 7 | (58.3%) | 19 | (51.4%) |
No | 5 | (41.7%) | 18 | (48.6%) |